ARCHIVES

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

Reinventing NCI: Rimer Says Report Consistent with Her Goals For DCCPS

October 17, 1997

Network Should Collect Some Environmental Information: Collins

August 9, 1996

Gleevec Better Than Interferon For Newly Diagnosed CML

May 31, 2002

Guest Editorial: The Walue of Quality of Life Data In Judging Patient Benefit: experts Respond To ODAC

September 3, 1999

Illinois Congressman Makes Public Commitment to Approval Of NCI’s FY 1991 Bypass Budget

January 19, 1990

GlaxoSmithKline Partners With MD Anderson, Fred Hutchinson

December 14, 2012